HIV-prevention drug to cost $40 a year from 2027
Geplaatst: 01 okt 2025 23:59
Gates Foundation and Unitaid announce generic versions of the twice-yearly HIV "prevention" injection, will be available from 2027 for approx $40 a year, in over 100 countries, with Indian pharmaceutical firms producing the drug under new agreements.
Generic versions of the HIV-prevention drug lenacapavir will cost $40 per year starting in 2027, announced Unitaid and the Gates Foundation. They have partnered with Indian pharmaceutical companies to produce affordable generics for low and middle-income countries.
With current costs of approximately $28,000 a year in the U.S., this initiative aims to "scale up HIV prevention". The drug has been proven to reduce HIV transmission risk by over 99.9%. Partnerships will also ensure production in regions beyond India in the future.
Read more: https://www.disclose.tv/id/zcfrrk323w/
https://economictimes.indiatimes.com/in ... 098664.cms
Generic versions of the HIV-prevention drug lenacapavir will cost $40 per year starting in 2027, announced Unitaid and the Gates Foundation. They have partnered with Indian pharmaceutical companies to produce affordable generics for low and middle-income countries.
With current costs of approximately $28,000 a year in the U.S., this initiative aims to "scale up HIV prevention". The drug has been proven to reduce HIV transmission risk by over 99.9%. Partnerships will also ensure production in regions beyond India in the future.
Read more: https://www.disclose.tv/id/zcfrrk323w/
https://economictimes.indiatimes.com/in ... 098664.cms